wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48164214-99C19CE0-2CD1-46A9-B77B-3DD1853D30E8
Q48164214-99C19CE0-2CD1-46A9-B77B-3DD1853D30E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48164214-99C19CE0-2CD1-46A9-B77B-3DD1853D30E8
PARP inhibitors as potential therapeutic agents for various cancers: focus on niraparib and its first global approval for maintenance therapy of gynecologic cancers.
P2860
Q48164214-99C19CE0-2CD1-46A9-B77B-3DD1853D30E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48164214-99C19CE0-2CD1-46A9-B77B-3DD1853D30E8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d1c537ebca3a1f22cd88181f8d7b13040e5d1a8
P2860
Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.